I highly suspect this is to cover other market losses or cease on buying down big board tickers.
That said.... I think 2019 is going to be a heck of an awesome year in general for MMJ companies. I truly expect that we will see the reclassification of MJ which will open the doors for public funded studies and for large funds to begin investing in sound companies. It appears that NXEN knows and expects this and is planning to capitalize on it. I would not be surprised to see a huge boost in share price when we enter the CSE and then an announcement with the intent to uplist to a more heavily regulated exchange that would require share place at 4 bucks or higher. This would come with an announcement of a deal with a government most likely at which time I'm sure we would get a lot of notice and see come awesome opportunities. This may play out into 2020 but for those that invest at these levels I think that since tech is a little played out the market will move to another industry and Pharma specifically MMJ has never been so prime. JMO
News 
Market Data 
Discover 
